|Bid||28.91 x 1300|
|Ask||28.93 x 800|
|Day's range||27.11 - 29.06|
|52-week range||13.19 - 57.02|
|Beta (5Y monthly)||0.71|
|PE ratio (TTM)||N/A|
|Earnings date||08 Dec 2022|
|Forward dividend & yield||N/A (N/A)|
|1y target est||32.36|
WILIMINGTON, Del., November 16, 2022--Phreesia is proud to announce that Sara DiNardo, the company’s Vice President of Client Solutions, has been named to The Software Report’s list of the Top 50 Women Leaders in SaaS of 2022.
MEI Pharma, Inc. (MEIP) delivered earnings and revenue surprises of 0% and 10.46%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Neovasc (NVCN) delivered earnings and revenue surprises of -6.38% and 7.70%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?